Psoriasis – Current and Future Players – New Research Available

London (PRWEB) October 23, 2013

Psoriasis - Current and Future Players

Summary

GlobalData has released its pharma report, Psoriasis - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Psoriasis Market. The report identifies and analyses the key companies shaping and driving the global Psoriasis market. The report provides insight into the competitive Psoriasis landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalDatas team of industry experts.

Scope

-Investigation of current and future market competition for Psoriasis -Competitor assessment -Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. -Strategic assessment of Psoriasis sector through market impact analysis, future market scenario and company analysis

Reasons to buy

-Gain a high level view of the trends shaping and driving Psoriasis Market -Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. -Create an effective counter-strategy to gain a competitive advantage against those currently in the market -Whats the next big thing in the global Psoriasis market landscape? Identify, understand and capitalize

Table of Contents

1 Table of Contents 5 1.1 List of Tables 7 1.2 List of Figures 8 2 Introduction 9 2.1 Catalyst 9 2.2 Related Reports 9 3 Market Outlook 12 3.1 Global Markets 12 3.1.1 Forecast 12 3.1.2 Drivers and Barriers Global Issues 16 4 Current and Future Players 20 4.1 Overview 20 4.2 Trends in Corporate Strategy 24 4.3 Company Profiles 26 4.3.1 Amgen 26 4.3.2 AbbVie (Abbott) 29 4.3.3 Johnson & Johnson 31 4.3.4 Novartis 33 4.3.5 Pfizer 35 4.3.6 Eli Lilly 37 4.3.7 Merck 39 4.3.8 LEO Pharma 41 4.3.9 Celgene 44 5 Appendix 46 5.1 Bibliography 46 5.2 Abbreviations 47 5.3 Methodology 48 5.4 Forecasting Methodology 48 5.4.1 Diagnosed Psoriasis Patients 48 5.4.2 Percent Drug-Treated Patients 49 5.4.3 Drugs Included in Each Therapeutic Class 49 5.4.4 Launch and Patent Expiry Dates 50 5.4.5 General Pricing Assumptions 51 5.4.6 Individual Drug Assumptions 52 5.4.7 Generic Erosion 56 5.4.8 Pricing of Pipeline agents 56 5.5 Physicians and Specialists Included in this Study 57 5.6 Primary Research Prescriber Survey 58 5.7 About the Authors 59 5.7.1 Analysts 59 5.7.2 Global Head of Healthcare 60 5.8 About GlobalData 61 5.9 Disclaimer 61

See the original post:
Psoriasis - Current and Future Players – New Research Available